SMS has Major Role to Play for Swine Flu Vaccination

iPLATOFrom today GPs will be receiving deliveries of the Pandemrix vaccine and will begin contacting 'at risk' groups for Swine Flu vaccination appointments. It was recently reported that there are fears that the backlog of post following the current Royal Mail strikes will affect the programme, resulting in 'at risk' groups missing their appointments and therefore delaying getting their vaccination. Sir Liam Donaldson, the chief medical officer has warned that thousands of people could miss appointments for their swine flu vaccine due to these postal strikes.

In response to this difficult situation, the Department of Health is now actively encouraging GPs and hospitals to use alternative methods of communication to combat the current limitations of the Royal Mail service. Text messaging is seen as a method that could play a key role in ensuring the maximum number of 'at risk' patients are engaged with. It has also been reported that a number of doctors are already considering sending text messages to patients to invite them for the swine flu vaccination rather than letters.

Text messaging has proven itself to be an extremely effective and immediate way to contact 'at risk' groups of patients, when used for the support of health promotion initiatives such as Smoking Cessation and seasonal Flu. As such, it is a resource that if used to engage with target groups relevant for Swine Flu, could make a real difference, especially if communication via the mail service remains problematic. When compared to other methods of patient engagement, text messaging consistently proves to be a considerably cheaper and more responsive communication channel than other options available (letters, landline call etc).

iPLATO's flagship text messaging platform, Patient Care Messaging (PCM), is currently being used by GPs across 43 Primary Care Trusts. As a result, the iPLATO network of users represents a very significant resource to be called on in an emergency such as this.

The iPLATO service is a web based text messaging system hosted within NHSnet that integrates to all major GP administration systems, allowing fully automated appointment reminders and targeted group messaging. Patients can respond via text if they wish, with replies being automatically forwarded to a pre-assigned email address. With an estimated 82% of the UK population owning a mobile phone, it is anticipated surgeries will be able to reach a significant number of their patients in this way.

iPLATO are currently actively engaging with their network of PCTs and GPs to highlight the potential of SMS GP-led Swine Flu vaccine invitations.

Related news articles:

About iPLATO
iPLATO Healthcare is a London based innovation company dedicated to mobile health since 2006. iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with healthcare professionals and provider organisations, support patients in achieving longer, healthier lives.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...